Benitec Biopharma Inc.BNTCNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank17
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-84.82%
↓ 41% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive declineDecelerating
Average
-60.04%
Historical baseline
PeriodValue
2025-84.82%
2024-18.43%
2023-6.87%
2022-31.32%
2021-64.18%
2020-513.44%
2019123.42%
201846.29%
201736.21%
2016-87.28%